The Trump administration has proven to be incompetent in filling crucial roles with qualified people, evidenced by an anti-EPA EPA head and an anti-DOE head of DOE. Now, the president has nominated a non-scientist who is also known as a climate change denier to be the head of NASA. This appointment could have far-reaching and devastating consequences for the US and the rest of the world.
The nominee in question is Rep. Jim Bridenstine, R-Okla., The Chicago Tribune reports. He is a former pilot and a known climate change denier. He does have a plan for NASA, however, which involves a vision of a future where humans become a multi-planet species. That way, oil and other major companies can destroy the environments of other worlds as well.
On the plus side, it does seem like Bridenstine has expressed interest in bridging NASA and commercial spaceflight companies in the past, which might be good news for those who want ventures like SpaceX to succeed. Unfortunately, this is just not enough to justify his placement as the head to one of the most valuable agencies in the fight against climate change.
As Phil Plait wrote on Syfy, this nomination is a terrible idea for several reasons. One is the fact that Bridenstine is a politician, not a scientist. Since NASA is a structure that is largely based on science and the scientific pursuits, putting someone in charge who only has a rudimentary grasp of any field of science just makes no sense.
What’s more, NASA provides climate scientists with some very valuable data. Using satellites to track weather patterns, ice shifts, and desertification progression is just one thing that makes the agency so invaluable. By putting an anti-climate change figure as the head of NASA, Trump essentially cut the legs of scientists right out from under them.


Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Tabletop particle accelerator could transform medicine and materials science
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Expands Brain Implant Trials with 12 Global Patients
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 



